Benefit of simultaneous rhG-CSF and methylprednisolone 'pulse' therapy for methotrexate-induced bone marrow failure in rheumatoid arthritis

MLA

H, Kondo, and Date Y. “Benefit of Simultaneous RhG-CSF and Methylprednisolone ‘Pulse’ Therapy for Methotrexate-Induced Bone Marrow Failure in Rheumatoid Arthritis.” International Journal of Hematology, vol. 65, no. 2, Feb. 1997. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........e2d198d2fc014be3422e42892b9e7c77&authtype=sso&custid=ns315887.

APA

H, K., & Y, D. (1997). Benefit of simultaneous rhG-CSF and methylprednisolone “pulse” therapy for methotrexate-induced bone marrow failure in rheumatoid arthritis. International Journal of Hematology, 65(2).

Chicago

H, Kondo, and Date Y. 1997. “Benefit of Simultaneous RhG-CSF and Methylprednisolone ‘Pulse’ Therapy for Methotrexate-Induced Bone Marrow Failure in Rheumatoid Arthritis.” International Journal of Hematology 65 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........e2d198d2fc014be3422e42892b9e7c77&authtype=sso&custid=ns315887.